3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
29
Lymphoma, Large B-Cell, Diffuse
26
Burkitt Lymphoma
20
Lymphoma, Follicular
14
Lymphoma
14
Lymphoma, Non-Hodgkin
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Neoplasms
8
Lymphoma, B-Cell
6
Recurrence
5
Prostatic Neoplasms, Castration-Resistant
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Lymphoma, B-Cell, Marginal Zone
5
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Leukemia, Biphenotypic, Acute
4
Ovarian Neoplasms
3
Lymphoproliferative Disorders
3
Leukemia
3
Hodgkin Disease
3
Prostate Cancer Metastatic
2
Plasmablastic Lymphoma
2
Multiple Myeloma
2
Metastatic Castration-resistant Prostate Cancer
2
Melanoma
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, T-Cell
2
Lymphoma, Mantle-Cell
2
Immunoblastic Lymphadenopathy
2
Interventions
Specimen Handling
5
Biopsy
5
Whole-Body Irradiation
3
Mycophenolic Acid
3
Cyclosporine
3
Cyclophosphamide
3
Azacitidine
3
venetoclax
2
ruxolitinib
2
fludarabine phosphate
2
decitabine and cedazuridine drug combination
2
Sirolimus
2
Melphalan
2
Injections
2
Granulocyte Colony-Stimulating Factor
2
Decitabine
2
Busulfan
2
veliparib
1
tocilizumab
1
tagraxofusp
1
posaconazole
1
peginterferon alfa-2b
1
iadademstat
1
gilteritinib
1
fludarabine
1
fedratinib
1
axatilimab
1
Tranexamic Acid
1
Topotecan
1
Tacrolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic-Myeloproliferative Diseases
×
Prednisone
×
90 days
×
Clear all
No trials found.